Fig. 1.
Fig. 1. IL-3, Epo, and Tpo activate both JNK1 and JNK2 in in vitro kinase assay. FDC-P2 cells (upper panel), FD-EPO cells (middle panel), and FD-TPO cells (lower panel) were stimulated with IL-3, Epo, and Tpo, respectively, for the indicated time up to 120 minutes. JNK1 (A) and JNK2 (B) activity was measured in the immunoprecipitates with anti-JNK1– and anti-JNK2–specific antibody and [γ-32P]ATP and GST-c-Jun as a substrate. Arrows indicate the phosphorylated GST-c-Jun (molecular weight, 35 kD).

IL-3, Epo, and Tpo activate both JNK1 and JNK2 in in vitro kinase assay. FDC-P2 cells (upper panel), FD-EPO cells (middle panel), and FD-TPO cells (lower panel) were stimulated with IL-3, Epo, and Tpo, respectively, for the indicated time up to 120 minutes. JNK1 (A) and JNK2 (B) activity was measured in the immunoprecipitates with anti-JNK1– and anti-JNK2–specific antibody and [γ-32P]ATP and GST-c-Jun as a substrate. Arrows indicate the phosphorylated GST-c-Jun (molecular weight, 35 kD).

Close Modal

or Create an Account

Close Modal
Close Modal